Uromigos Live-Prostate Cancer
Advertisement
Listen to the podcast format of the panel on radioligand data in prostate cancer from Uromigos Live 2024.
Listen to the podcast format of the panel on T cell directed therapy in prostate cancer from Uromigos Live 2024.
Christopher Sweeney talks about prostate cancer trials investigating the use of ADT + docetaxel or cabazitaxel.
Christopher Sweeney, MBBS, gives us his insight on the future of prostate cancer care and research in the year 2027.
Nick James, MBBS, PhD, FRCP, FRCR, discusses his outlook on the future of prostate cancer treatment in the year 2027.
Daniel George, MD, Duke University School of Medicine, gives us insight on what to expect from the future of mHSPC treatment.
Neeraj Agarwal, MD, Professor of Medicine, gives his outlook on the future of cancer care and treatment for mHSPC in 2027.
Rana McKay, MD, GU Medical Oncologist from UCSD, gives her outlook on the future of prostate cancer care in the year 2025.
Michael Morris, MD, of Memorial Sloan Kettering Cancer Center gives his predictions for the future of mHSPC treatment.
Featuring panelists Neeraj Agarwal, MD, Daniel George, MD, Nick James, MBBS, PhD, FRCP, FRCR, Rana McKay, MD, and more.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.